These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 31724495)
41. Long non‑coding RNA RP1‑163G9.1 is downregulated in gastric adenocarcinoma and is associated with a poor prognosis. Sun B; Dang Y; Zhang F; Li K; Ouyang X; Wang K; Huang Q Oncol Rep; 2019 Jun; 41(6):3575-3585. PubMed ID: 31002370 [TBL] [Abstract][Full Text] [Related]
42. Correlation of overexpression of nestin with expression of epithelial-mesenchymal transition-related proteins in gastric adenocarcinoma. Liu JK; Chen WC; Ji XZ; Zheng WH; Han W; An J Asian Pac J Cancer Prev; 2015; 16(7):2777-83. PubMed ID: 25854362 [TBL] [Abstract][Full Text] [Related]
43. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion. Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471 [TBL] [Abstract][Full Text] [Related]
44. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer. Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493 [TBL] [Abstract][Full Text] [Related]
45. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer. Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666 [TBL] [Abstract][Full Text] [Related]
46. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
47. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Sathyanarayanan A; Chandrasekaran KS; Karunagaran D Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466 [TBL] [Abstract][Full Text] [Related]
48. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer. Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1. Yang Y; Tao X; Li CB; Wang CM Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739 [TBL] [Abstract][Full Text] [Related]
50. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation. Wang X; Li Y; Fang Z; Li Y Bioengineered; 2021 Dec; 12(2):12204-12214. PubMed ID: 34783304 [TBL] [Abstract][Full Text] [Related]
51. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients. Zhang D; Zhou S; Liu B Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437 [TBL] [Abstract][Full Text] [Related]
52. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
53. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
54. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
55. Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma. Zhao X; Li R; Wang Q; Wu M; Wang Y Diagn Pathol; 2019 Oct; 14(1):118. PubMed ID: 31651348 [TBL] [Abstract][Full Text] [Related]
56. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
57. SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion. Chen Z; Raghoonundun C; Chen W; Zhang Y; Tang W; Fan X; Shi X Biochem Biophys Res Commun; 2018 Apr; 498(3):579-585. PubMed ID: 29522714 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
59. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer. Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464 [TBL] [Abstract][Full Text] [Related]
60. Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells. Jiang R; Zhao C; Wang X; Wang S; Sun X; Tian Y; Song W Med Sci Monit; 2016 Mar; 22():937-42. PubMed ID: 27001185 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]